Serum levels of cytokines in infants treated with conbercept for retinopathy of prematurity
Authors:
Open Access
- 29 July 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-8
Abstract
Intravitreal anti-vascular endothelial growth factor (VEGF) agents have revolutionized the treatment of retinopathy of prematurity (ROP); however, there are concerns regarding the potential systemic complications caused by those treatments. This study aimed to determine the serum concentrations of cytokines in infants with ROP and to evaluate the changes in serum VEGF concentrations after intravitreal conbercept (IVC). Sixty infants with ROP treated with IVC 0.25 mg were included. Blood samples were collected before treatment as well as 1 week and 4 weeks after treatment. Serum levels of 45 types of cytokines were measured by a multiplex bead assay. We observed that IVC 0.25 mg in ROP patients suppressed the circulating levels of VEGF-A and VEGF-D as of 1 week after injection, and these growth factor levels returned to baseline at 4 weeks. No significant differences were observed in the serum levels of the other cytokines between baseline and 1 or 4 weeks after IVC.Keywords
All Related Versions
Funding Information
- Beijing Bethune Charitable Foundation (2018-Z-08)
This publication has 47 references indexed in Scilit:
- Inhibition of EGF Signaling Protects the Diabetic Retina from Insulin-Induced Vascular LeakageThe American Journal of Pathology, 2013
- Serum concentrations of vascular endothelial growth factor in an infant treated with ranibizumab for retinopathy of prematurityActa Ophthalmologica, 2012
- Serum Concentrations of Bevacizumab (Avastin) and Vascular Endothelial Growth Factor in Infants With Retinopathy of PrematurityAmerican Journal of Ophthalmology, 2012
- Perinatal infection, inflammation, and retinopathy of prematuritySeminars in Fetal and Neonatal Medicine, 2012
- Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbitsClinical Ophthalmology, 2011
- Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurityClinical Ophthalmology, 2010
- Perinatal Systemic Inflammatory Response Syndrome and Retinopathy of PrematurityPediatric Research, 2010
- Outcome of Early-Onset Sepsis in a National Cohort of Very Low Birth Weight InfantsPediatrics, 2010
- Predicted biological activity of intravitreal VEGF TrapBritish Journal of Ophthalmology, 2008
- Umbilical cord serum vascular endothelial growth factor (VEGF) levels in normal pregnancies and in pregnancies complicated by preterm delivery or pre‐eclampsiaInternational Journal of Gynecology & Obstetrics, 2004